2019
DOI: 10.1152/physiolgenomics.00054.2019
|View full text |Cite
|
Sign up to set email alerts
|

Germ-line genetic variation in the immunoglobulin heavy chain creates stroke susceptibility in the spontaneously hypertensive rat

Abstract: The risk of cerebrovascular disease in stroke-prone spontaneously hypertensive rats (SHR-A3/SHRSP) arises from naturally occurring genetic variation. In the present study we show the involvement of SHR genetic variation that affects antibody formation and function in the pathogenesis of stroke. We have tested the involvement in susceptibility to stroke of genetic variation in IgH, the gene encoding the immunoglobulin heavy chain by congenic substitution. This gene contains functional natural variation in SHR-A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…To date, few diseases have been robustly associated to IGH (24,25,72,73). We previously suggested this was due to sparse locus coverage of genotyping arrays and an inability of array SNPs to tag functional IGH variants (2,3).…”
Section: Discussionmentioning
confidence: 99%
“…To date, few diseases have been robustly associated to IGH (24,25,72,73). We previously suggested this was due to sparse locus coverage of genotyping arrays and an inability of array SNPs to tag functional IGH variants (2,3).…”
Section: Discussionmentioning
confidence: 99%
“…To date, few diseases have been robustly associated to IGH 22,23,70,71 . We previously suggested this was due to sparse locus coverage of genotyping arrays and an inability of array SNPs to tag functional IGH variants 4,20 .…”
Section: Discussionmentioning
confidence: 99%
“…Genetic differences, such as those observed between 129S1/SvImJ and C57BL/6 (Figures 2A, B), when considered alongside observations that have been made for regulatory elements elsewhere in the genome, raise important questions about the potential for Ig genetic diversity to impact V(D)J recombination. First, there are numerous examples for which germline V H variants have been shown to contribute to antigen specificity (75-79) and associate with disease and clinical phenotypes in the context of infection, inflammation, and vaccination (31,32,(80)(81)(82)(83). Second, both large structural variants and single nucleotide polymorphisms could modify key regulatory elements, such as CTCF sites and in promoters and enhancers, either through the disruption of these elements (e.g.…”
Section: Discussionmentioning
confidence: 99%